INSMED Inc — Director's Dealing 2016

Nov 15, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INSMED Inc (INSM)
CIK: 0001104506
Period of Report: 2016-11-14

Reporting Person: Drechsler Andrew T (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-11-14	Common Stock	M	20000	$6.65	Acquired	20000	Direct
2016-11-14	Common Stock	S	20000	$14.67	Disposed	0	Direct
2016-11-14	Common Stock	M	25000	$6.90	Acquired	25000	Direct
2016-11-14	Common Stock	S	25000	$14.67	Disposed	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-11-14	Stock Option	$6.65	M	20000	Disposed	2022-11-07	Common Stock (20000)	Direct
2016-11-14	Stock Option	$6.90	M	25000	Disposed	2023-03-20	Common Stock (25000)	Direct

Footnotes

F1: The price in column 4 is a weighted average price. The prices actually paid by the Reporting Person in these transactions range from $14.22 to $14.915.

F2: Stock options granted under the Company's 2000 Stock Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.

F3: Stock Options granted under the Company's 2000 Stock Incentive Plan. On March 20, 2013, the Reporting Person was granted an option to purchase 50,000 shares of common stock. The option vests in two equal installments based upon the Company's satisfaction of two separate performance metrics. One such performance metric was met by the Company on February 26, 2015, resulting in vesting of the option as to 25,000 shares.